Great Valley Advisor Group »

Summit Therapeutics shares owned by Great Valley Advisor Group

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Great Valley Advisor Group from 13F filings

Historical chart of Great Valley Advisor Group investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Great Valley Advisor Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Great Valley Advisor Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $89k 34k 2.61
2023-09-30 $64k 34k 1.87
2023-06-30 $85k 34k 2.51
2023-03-31 $60k 34k 1.75

More positions owned by Great Valley Advisor Group

Vanguard Scottsdale Fds Int-term Corp (VCIT)
Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr Ser Tr Portfolio S&p500 (SPLG)
NVIDIA Corporation (NVDA)
American Centy Etf Tr Us Quality Grow (QGRO)
Amazon (AMZN)
Wisdomtree Tr Us Largecap Divd (DLN)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Spdr Ser Tr Portfolio Agrgte (SPAB)
Spdr Ser Tr Portfolio S&p400 (SPMD)
Ishares Tr Msci Acwi Etf (ACWI)
Spdr Ser Tr Portfolio Ln Tsr (SPTL)
Spdr Ser Tr Portfolio S&p600 (SPSM)
Spdr Index Shs Fds Msci Eafe Strtgc (QEFA)

View all positions for Great Valley Advisor Group

Top funds holding Summit Therapeutics

Vanguard Group
Charles Schwab Investment Management
Steward Partners Investment Advisory
ALPS Advisors
Barclays
Bank of New York Mellon
Jpmorgan Chase & Co
Swiss National Bank
Goldman Sachs Group
UBS Group
Advisor Group Holdings
China Universal Asset Management
Rhumbline Advisers
CSS
Bank of America Corporation

View all funds holding Summit Therapeutics